Canadian drug review deadline fast approaching

Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version

The Canadian Agency for Drugs and Technologies in Health (CADTH) is inviting stakeholder comments and feedback on the Proposed Approach for Posting the Common Drug Review (CDR) Clinical and Pharmacoeconomic Review Reports on the CADTH website.

Please email your feedback by January 25 (20 business days), to All feedback will be considered in finalizing the approach to posting CDR Clinical and Pharmacoeconomic Review Reports.

How to submit your feedback:

To provide feedback, you must identify yourself — feedback provided by individuals who do not identify themselves and the organization they represent will not be considered.

Only one response per organization will be considered. If more than one response is received, only the first response that is received will be considered.

Feedback should be provided in a Microsoft Word document using 11-point font.

The maximum length of feedback is three (3) pages.

Feedback should be presented clearly and succinctly. The issue(s) should be clearly stated and specific reference should be made to the section of the document under discussion (i.e., section title, page number, and paragraph).

If you have any questions about the feedback process, please email

Visit their website for more information.